Cegedim SA (EPA: CGM)
France
· Delayed Price · Currency is EUR 12.95
-0.50 (-3.72%)
Dec 20, 2024, 5:35 PM CET
Cegedim Revenue
Cegedim had revenue of 319.00M EUR in the half year ending June 30, 2024, with 19.22% growth. This brings the company's revenue in the last twelve months to 633.98M, up 7.70% year-over-year. In the year 2023, Cegedim had annual revenue of 616.00M with 10.95% growth.
Revenue (ttm)
633.98M
Revenue Growth
+7.70%
P/S Ratio
0.28
Revenue / Employee
93.66K
Employees
6,582
Market Cap
177.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 616.00M | 60.79M | 10.95% |
| Dec 31, 2022 | 555.21M | 30.50M | 5.81% |
| Dec 31, 2021 | 524.71M | 27.77M | 5.59% |
| Dec 31, 2020 | 496.94M | -6.81M | -1.35% |
| Dec 31, 2019 | 503.75M | 36.06M | 7.71% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |